Healthcare

Vectus Biosystems Limited fits that profile. On a market snapshot dated 22 July 2026 the stock was shown down roughly 14.3% intraday. The purpose of this article is not to explain a move that may have no disclosed cause, but to give readers a …

Corporate announcements from clinical-stage biotechnology companies are not all created equal. Some report clinical milestones, capital raisings or partnership deals, while others are purely administrative filings that keep a company's records compliant with ASX rules. The latest lodgement from Racura Oncology Limited (ASX: RAC) …

Racura Oncology Limited (ASX:RAC) has secured a place on the programme of a focused scientific gathering. The company confirmed that its abstract describing the CPACS study has been accepted for a poster presentation at the Global Cardio-Oncology Summit 2026. For a clinical-stage biopharmaceutical company, …

Racura Oncology Limited (ASX: RAC) has reported an early governance milestone in its CPACS study, one that speaks less to headline efficacy than to the machinery that keeps an early-stage cancer trial safe and credible. According to an abstract accepted for poster presentation at …

Anthracycline chemotherapy such as doxorubicin has treated cancer for decades, yet it carries a well-known cost: irreversible heart damage. That trade-off frames the headline's question: could a cancer treatment work without inflicting the same cardiac injury? Racura Oncology Limited (ASX:RAC) is now running an …

Racura Oncology Limited (ASX:RAC) recently gave the market two very different kinds of information within days of each other. One was routine capital-structure paperwork: the removal of a class of expired options from its register. The other, arriving through clinical and conference updates, concerned …

Racura Oncology Limited (ASX: RAC) has told the market it will open its doors to investors in early August 2026, and for shareholders following the company that event is worth anticipating carefully. Racura, an ASX-listed clinical-stage biopharmaceutical company whose stated mission is to "silence …